(Q36735647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

main subject

probiotics

0 references

irritable bowel syndrome

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Quigley EM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

Neurogastroenterology and Motility

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

166-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300285%20AND%20SRC:MED&resulttype=core&format=json

Systematic review: Complementary and alternative medicine in the irritable bowel syndrome

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

The use of probiotics in functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Modulation of human dendritic cell phenotype and function by probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

DNA from probiotic bacteria modulates murine and human epithelial and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00879.X